Rapid Micro Biosystems, Inc. - Class A Common Stock (RPID)
Competitors to Rapid Micro Biosystems, Inc. - Class A Common Stock (RPID)
Becton, Dickinson and Company BDX +0.20%
Becton, Dickinson and Company (BD) is a leading global medical technology company known for its unique diagnostic solutions, including microbiological testing. They have a strong focus on innovation and product development in the diagnostics sector which puts them in direct competition with Rapid Micro Biosystems in areas like automated microbiology testing and systems. BD benefits from a well-established reputation and extensive experience in the market, giving it an advantage in terms of customer loyalty and resource availability.
bioMérieux
bioMérieux is a global leader in in vitro diagnostics and microbiology solutions. They compete with Rapid Micro Biosystems through their extensive range of products focused on infectious disease diagnostics, quality control, and environmental monitoring. bioMérieux has a strong brand presence and a lengthy track record, which provides them with significant trust and reliability among healthcare professionals and institutions. Their vast distribution network and established customer relationships allow them to maintain a competitive edge.
MilliporeSigma
MilliporeSigma, the life science division of Merck KGaA, competes with Rapid Micro Biosystems by providing various products and services related to biological testing and quality assurance in manufacturing processes. Their expertise in materials and equipment for labs places them in a strong position within various markets, such as pharmaceuticals and bioprocessing. They boast a robust customer base and established product lines that allow them to compete effectively, although their focus is broader compared to Rapid Micro's specialized offerings.
QIAGEN N.V. QGEN +1.80%
QIAGEN N.V. provides solutions for sample and assay technologies that are integral to molecular diagnostics and microbiology. They compete with Rapid Micro Biosystems by offering advanced pathogen detection and quantification systems that are used in laboratories and hospitals worldwide. QIAGEN has a strong focus on integrating digital PCR and NGS technologies, positioning themselves as an innovator in the genetic testing market. Their established reputation in precision medicine provides them with a competitive advantage in high-end diagnostic applications.
Thermo Fisher Scientific Inc. TMO +0.49%
Thermo Fisher Scientific offers a broad range of life sciences tools and laboratory equipment, including solutions for microbiological testing and contamination detection. They compete with Rapid Micro Biosystems by providing integrated laboratory software and solutions that appeal to large research institutions and pharmaceutical companies. Their extensive product offerings, significant resources, and innovations in automation give them a competitive advantage, particularly in large-scale laboratories.